Enliven Therapeutics, Inc. (ELVN)
27.90
+0.70
(+2.55%)
USD |
NASDAQ |
Jan 22, 11:51
Enliven Therapeutics Total Assets (Quarterly): 490.88M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Coherus Oncology, Inc. | 516.52M |
| Allogene Therapeutics, Inc. | 439.77M |
| Pyxis Oncology, Inc. | 105.60M |
| CEL-SCI Corp. | 28.16M |
| AIM ImmunoTech, Inc. | 5.494M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 14.75M |
| Shareholders Equity (Quarterly) | 476.12M |
| Debt to Equity Ratio | 0.0008 |
| Current Ratio | 32.95 |
| Net Debt Paydown Yield | -0.00% |